Can Artificial Intelligence Identify Those at High Risk and Shift the Lung Cancer Screening Paradigm?

Regulatory News for April 24, 2024

Mounting Evidence Supporting Neoadjuvant ChemoIO Means Surgeons Must Adapt

More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care

A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib

European Commission Approves Tislelizumab for Three Indications in Non-Small Cell Lung Cancer

In Case You Missed It: Recent News from IASLC

WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers

AEGEAN Shows Benefit with the Addition of Perioperative Durvalumab to Neoadjuvant Chemotherapy in Resectable NSCLC

World Conference Plenary Addresses Barriers to—and Opportunities for—Lung Cancer Care in Low- to Middle-Income Countries

Lectureship Award Winners Discuss Broad Thoracic Oncology Topics During WCLC 23 Plenary Session

Inaugural Amazing Case Race Winners Announced